A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release
- PMID: 11549733
- PMCID: PMC6762992
- DOI: 10.1523/JNEUROSCI.21-18-07226.2001
A novel action of alzheimer's amyloid beta-protein (Abeta): oligomeric Abeta promotes lipid release
Abstract
Interactions between amyloid beta-protein (Abeta) and lipids have been suggested to play important roles in the pathogenesis of Alzheimer's disease. However, the molecular mechanism underlying these interactions has not been fully understood. We examined the effect of Abeta on lipid metabolism in cultured neurons and astrocytes and found that oligomeric Abeta, but not monomeric or fibrillar Abeta, promoted lipid release from both types of cells in a dose- and time-dependent manner. The main components of lipids released after the addition of Abeta were cholesterol, phospholipids, and monosialoganglioside (GM1). Density-gradient and electron microscopic analyses of the conditioned media demonstrated that these Abeta and lipids formed particles and were recovered from the fractions at densities of approximately 1.08-1.18 g/ml, which were similar to those of high-density lipoprotein (HDL) generated by apolipoproteins. The lipid release mediated by Abeta was abolished by concomitant treatment with Congo red and the PKC inhibitor, H7, whereas it was not inhibited with N-acetyl-l-cysteine. These Abeta-lipid particles were not internalized into neurons, whereas HDL-like particles produced by apolipoprotein E were internalized. Our findings indicate that oligomeric Abeta promotes lipid release from neuronal membrane, which may lead to the disruption of neuronal lipid homeostasis and the loss of neuronal function.
Figures
Similar articles
-
Relationship between beta-amyloid degradation and the 26S proteasome in neural cells.Exp Neurol. 2003 Apr;180(2):131-43. doi: 10.1016/s0014-4886(02)00060-2. Exp Neurol. 2003. PMID: 12684027
-
Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture.J Neurochem. 2000 Mar;74(3):1008-16. doi: 10.1046/j.1471-4159.2000.0741008.x. J Neurochem. 2000. PMID: 10693931
-
Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle.J Biol Chem. 2000 Oct 13;275(41):31770-7. doi: 10.1074/jbc.M002796200. J Biol Chem. 2000. PMID: 10918055
-
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.Free Radic Res. 2002 Dec;36(12):1307-13. doi: 10.1080/1071576021000049890. Free Radic Res. 2002. PMID: 12607822 Review.
-
Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer's Disease.Int J Mol Sci. 2022 Oct 11;23(20):12092. doi: 10.3390/ijms232012092. Int J Mol Sci. 2022. PMID: 36292947 Free PMC article. Review.
Cited by
-
Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer's patients: A double-blind placebo-controlled randomized clinical trial.IBRO Neurosci Rep. 2024 Jul 20;17:108-121. doi: 10.1016/j.ibneur.2024.07.002. eCollection 2024 Dec. IBRO Neurosci Rep. 2024. PMID: 39139290 Free PMC article.
-
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites.Alzheimers Dement (N Y). 2022 Apr 6;8(1):e12283. doi: 10.1002/trc2.12283. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35415204 Free PMC article.
-
Transferrin-Pep63-liposomes accelerate the clearance of Aβ and rescue impaired synaptic plasticity in early Alzheimer's disease models.Cell Death Discov. 2021 Sep 21;7(1):256. doi: 10.1038/s41420-021-00639-1. Cell Death Discov. 2021. PMID: 34548476 Free PMC article.
-
Quinovic Acid Impedes Cholesterol Dyshomeostasis, Oxidative Stress, and Neurodegeneration in an Amyloid-β-Induced Mouse Model.Oxid Med Cell Longev. 2020 Nov 20;2020:9523758. doi: 10.1155/2020/9523758. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33274012 Free PMC article.
-
Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.Front Cell Neurosci. 2019 Jul 18;13:309. doi: 10.3389/fncel.2019.00309. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31379503 Free PMC article. Review.
References
-
- Avdulov NA, Chochina SV, Igbavboa U, Warden CS, Vassiliev AV, Wood WG. Lipid binding to amyloid β-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids. J Neurochem. 1997;69:1746–1752. - PubMed
-
- Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. Amyloid β-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem. 1996;271:32916–32922. - PubMed
-
- Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK. Acceleration of amyloid fibril formation by specific binding of Aβ(1–40) peptide to ganglioside-containing membrane vesicles. J Biol Chem. 1997;272:22987–22990. - PubMed
-
- Chui DH, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, Takahashi K, Gallyas F, Tabira T. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat Med. 1999;5:560–564. - PubMed
-
- Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical